News Releases

BASF Pharma Solutions today announced a global price increase for excipients and selected active pharmaceutical ingredients (APIs) supplied by the company.

BASF’s Intermediates division has advanced its sustainability strategy by converting the entire portfolio of acid chlorides and chloroformates manufactured at its Ludwigshafen site to using 100 percent renewable electricity credits.

BASF has broadened its offering for certified biomass-balanced methanol products  by adding the ISCC EU certification to its existing portfolio. Since mid-2025, BASF’s Intermediates division has been supplying biomass-balanced methanol that is certified under ISCC EU, enabling BASF to meet the full range of certification requirements across both the chemical and biofuel sectors. For the chemical industry, methanol is certified under the ISCC PLUS and REDcert² standards, while ISCC EU and REDcert-EU certifications address the specific regulatory needs of the biofuel sector. This comprehensive certification framework allows BASF to support its customers in different industries to achieve their sustainability goals and comply with regulatory requirements.

Florham Park, NJ, June 17, 2025 – BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.

This News Release is only available in English.

Ludwigshafen, Germany – BASF Aroma Ingredients has successfully launched L-Menthol FCC rPCF as its first product with a reduced Product Carbon Footprint (rPCF). Further rPCF product launches are planned to help customers achieve their ambitious Scope 3 carbon reduction targets. BASF's rPCF aroma ingredients come with a PCF reduction of about 10 to 15% compared to conventional BASF products.